Moxifloxacin Hydrochloride

Records for this ingredient, by country (identity only).

ATC — · 4 markets · 43 records

Moxifloxacin Hydrochloride 4 markets · 43 records Forms
Filters
MarketCZ 23SG 8FR 6AU 4

CZ 23 records · 6 shown of 6 Source Státní ústav pro kontrolu léčiv (S · Data as of 2026-11-01 · some records have no stated strength

  • 5.45 mg per mL / per unit basis not statedliquidMOXIFLOXACIN BROWN & BURKMOXIFLOXACIN MISOM、MOXIFLOXACIN OLIKLA
  • 436.37 mgtabletMOXIFLOXACIN OLIKLA
  • 27.25 mg per mL / per unit basis not statedliquidVIGAMOX
  • 437.5 mg per mL / per unit basis not statedinjectionMoxifloxacin Kabi
  • 436.8 mg per mL / per unit basis not statedinjectionAvelox 400mg tablets
  • 436.37 mg per mL / per unit basis not statedinjectionMOXIFLOXACIN OLIKLA
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名MOXIFLOXACINO NORMON ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 8 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 400 mgtabletFLONOXIN FILM-COATED TABLET 400MGFLOXSAFE 400 FILM COATED TABLET 400MG、JOYLOXIN INJECTION 400MG/250ML、MOLOXIN FILM-COATED TABLETS 400MG、MOXETERO MOXIFLOXACIN FILM-COATED TABLETS 400 MG、MOXIFCIN FILM COATED TABLET 400MG also in FR
  • 400 mg/250 mLinjectionMoxifloxacin Kabi 400mg Solution for Infusion also in FR
  • 5 mg/mL per mL / per unit basis not statedliquidMO-FLOREN OPHTHALMIC SOLUTION 0.5% USP

FR 6 records · 4 shown of 4 Source Base de données publique des médic · Data as of 2026-11-03

  • 400 mgtabletMOXIFLOXACINE KRKA 400 mg, comprimé pelliculéMOXIFLOXACINE SANDOZ 400 mg, comprimé pelliculé、MOXIFLOXACINE VIATRIS 400 mg, comprimé pelliculé also in SG
  • 400 mg/250 mLinjectionIZILOX 400 mg/250 ml, solution pour perfusion also in SG
  • 436.8 mgtabletMOXIFLOXACINE EG 400 mg, comprimé pelliculé
  • 436.32 mgtabletMOXIFLOXACINE ARROW 400 mg, comprimé pelliculé

AU 4 records · 3 shown of 3 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 1.75 mg/mL per mL / per unit basis not statedinjectionMOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bagMOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bottle unknown
  • 436 mg per mL / per unit basis not statedinjectionMOXIFLOXACIN-AFT moxifloxacin (as hydrochloride) 400 mg / 250 mL intravenous infusion injection bottle unknown
  • 1.74 mg/mL per mL / per unit basis not statedinjectionMOXIFLOXACIN-BAXTER moxifloxacin (as hydrochloride) 400 mg/250 mL solution for intravenous infusion bottle unknown

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.